Medical Research Finder

Loading…

© 2025 meRfi®

Medical Research Finder

Legal Notice
Privacy
Terms of Use

Gut microbiota / Evidence-based microbiome knowledge (incl. AI chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

AuthorsReferences (Sources)

meRfi® AI Chat

Carcinogenesis / Oncogenesis / Tumorigenesis

Welcome to meRfi-GM!

Please register to continue your trial period!

meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Register for a free trial

Navigation

Contents

Tumor cells during oncogenesis display unique carbohydrate chains, presenting new targets for cancer immunotherapy.
Mantuano et al. 2020

Although carcinogenesis is defined by de novo genetic alterations, its sustained progression is dependent upon its ability to evade the host’s immunity

Zitvogel et al. 2006 Nat Rev Immunol. 6: 715-27
Yamamoto et al. 2008 Blood 111(6): 3220-4
Schreiber et al. 2011 Science 331:1565-70
Chen & Mellman 2013 Immunity 39: 1–10
Montanari et al. 2015 Clin Adv Hematol Oncol. 13(8): 518-24
Upadhyay et al. 2015 Cancers 7: 736-62
Chen & Mellman 2017 Nature 541(7637): 321-330

Carcinogenesis refers to the complex, multi-step process by which normal cells transform into canc…

References (Sources)

Adenoma-linked barrier defects and microbial products drive IL-23/ IL-17-mediated tumor growth
Grivennikov et al. 2012 Nature 491(7423): 254-258
Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion
Schreiber et al. 2011 Science 331:1565-70
Review
Hodgkin lymphoma: targeting the tumor microenvironment as a therapeutic strategy
Montanari et al. 2015 Clin Adv Hematol Oncol. 13(8): 518-24
Interactions between the tumor suppressor p53 and immune responses
Menendez et al., 2012
Review
Oncology Meets Immunology: The Cancer-Immunity Cycle
Chen & Mellman 2013 Immunity 39: 1–10
Review
PD-1–PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma
Yamamoto et al. 2008 Blood 111(6): 3220-4
Tumor-associated carbohydrates and immunomodulatory lectins as targets for cancer immunotherapy
Rodrigues Mantuano et al. 2020
Review

AI Chat

12/16/2025

Chat with our artificial intelligence:

Links

Carcinogenesis - Wikipedia